Grant Services & Analysis

We support research teams throughout the proposal process to successfully obtain and maintain extramural funding.

two doctors reviewing information on computer screen
room of doctors and business people
Spotlight On
Navigating Large-Scale Proposal Support

The Research Development Team has compiled a list of resources to assist Medical School faculty and staff who are building interdisciplinary research teams and pursuing large-scale grant proposals.

How Grant Services & Analysis Supports Research
Research Development

Our Research Development professionals work with faculty to increase extramural funding. We connect faculty with opportunities; work with faculty on grant writing/editing; coordinate large-scale proposals; support faculty career development through programs like R01 Boot Camp; manage internal funding programs; provide bridging support; and assist with limited submissions.


“Pre-Award” constitutes anything that facilitates a proposal’s creation and submission, prior to the award being received. We offer resources for proposal preparation, using eResearch Proposal Management (eRPM), proposal routing, and proposal submission.


“Post-Award” comprises everything that happens to administer a research project, following the official award being received. We also maintain the Post-Award Procedures Manual, which represents the consolidation of the Medical School post-award procedures and best practices.

Research Data Analytics

Our office provides data for sections of the M-DASH and M-STAT systems. We collect data from the proposals submitted, as well as directly from the National Institutes of Health. We are also able to provide data based on award submissions and receipts.

Resources & Education

Our office also writes and maintains policies related to aspects of sponsored research in the Medical School, creates and holds training sessions on various research administration topics, and works on special projects that arise and need our expertise.

Frequently Asked Questions

Review answers to the most common questions regarding grant routing and review policy, budget/justification issues, NIH proposals and awards, eRPM, PAF, PHS, FCOI, access to data systems, and post-award.

Contact Us
Grant Services & Analysis
Medical School Office of Research
North Campus Research Complex, Building 520-3174
2800 Plymouth Road
Ann Arbor, MI 48109
Phone: 734-763-4272
About Us
Grant Services & Analysis is a unit of the Medical School Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the Michigan Medicine research community and supports biomedical science from insight to impact.
Upcoming Research Events All Office of Research Events
Federal and Institutional Requirements for Human Subject Research (Level I)
This course will introduce the basics of conducting human subject research in compliance with federal regulations and institutional practices.
CRISPR/Cas9 and Mouse ES Cell Training Class
Trainees will design, build, and validate CRISPR/Cas9 reagents in mouse ES cells, and learn how to work with mouse embryonic stem cells.
Elements of Informed Consent
This course offers an overview of informed consent in human subject research. The course will examine IRBMED’s standard consent template and focus on how it reflects federal requirements.
Introduction to eResearch
This course is intended for those unfamiliar with eResearch, the university’s electronic research administration site. This course will provide a basic knowledge of working in and using eResearch while examining the process for creating and submitting an initial project application.
Michigan Clinical Research Unit Open House
Over the past year, the Michigan Clinical Research Unit has undergone an expansive construction project to accommodate the required corridor for the new patient tower. The team is now thrilled to share the results at an upcoming Open House to tour the new space.
Waivers, Alterations, and Alternative Forms of Informed Consent (Level II)
This course offers an overview of some special situations relating to informed consent. Specifically, waivers and alterations of informed consent, waivers of documentation of informed consent, and obtaining consent from non-English speakers.
Reporting AEs, ORIOs, and UaPs
This course will identify what constitutes an Adverse Event, ORIO, and Unanticipated Problem and how such events impact risk to subjects. Additionally, the course will review the requirements of reporting such events to the IRB and other entities.
Nodexus Lunch and Learn
Join Nodexus and the Flow Cytometry Core for a Lunch and Learn about gentle and contamination-free cell sorting and high viability of sorted and recovered samples.
Amendments and Continuing Reviews
This course is a follow-up to Initial Project Applications and will examine the process for submitting amendments and scheduled continuing reviews to IRBMED using eResearch once a project’s initial application has been approved.
Featured Research News All Office of Research News FFMI fellowship
Office of Research
Fast Forward Medical Innovation Fellowship Program
The Fast Forward Medical Innovation Fellowship Program is a 6-12 month, part-time, action-based training program that educates U-M doctoral students and postdocs on the business elements of commercializing biomedical technologies.
fcvc innovation challenge presentation
Office of Research
Apply Today! 2024 Frankel Cardiovascular Center Innovation Challenge Open for Submissions
Now in its eighth year, the Frankel Cardiovascular Center (FCVC) Innovation Challenge is an annual pitch competition where teams can win funds for ideas impacting cardiovascular care.
Office of Research
Fast Forward Medical Innovation Releases 2023 Annual Report
Fast Forward Medical Innovation (FFMI) recently released their 2023 Annual Report, reflecting FY23 activity across the U-M Medical School. The highlights included 249 invention reports (up from 188 last year), 165 U-M Medical School faculty, staff, and trainee participants in 2023 education programs, and 16 startups funded (1 exited) by the Michigan Biomedical Venture Fund since launch.